Introduction: Introduction: AOD-9604 is a synthetic peptide fragment of human growth hormone (hGH 177191) engineered to replicate hGHs fat-metabolism effects without altering IGF-1 or glucose levels. In preclinical research, it promoted lipolysis (fat breakdown) and reduced lipogenesis (fat storage) through receptor-independent mechanisms. AOD-9604 Fast Facts Class: Synthetic hGH fragment analog (Tyr-hGH 177191) Intended purpose: Stimulate fat metabolism while avoiding hGHs growth or glucose effects Mechanism: Increases fat oxidation, enhances lipolysis, suppresses lipogenesis Distinct from hGH: Does not activate the growth hormone receptor or raise IGF-1 Development stage: Completed Phase II trials
However, other studies suggest that it provides no benefit
In some clinics, people receive lipotropic injections once a week, while other clinics suggest more frequent injections
Some individuals may experience mild injection-site reactions (e.g., redness, swelling) or occasional headaches
Astrocytes make up the majority of cells in the human central nervous system (CNS) and are absolutely essential for healthy brain function as they support metabolic, functional, structural, homeostatic, and neuroprotective functions [34,35]